関連する実験動画
Updated: May 12, 2026

10:56
Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale
Published on: May 17, 2014
mTORとS6K1は,ダイナミックなタンパク質交換とオーダーされたリン酸化イベントを通じた翻訳前始動複合体の中間組成を介しています
Marina K Holz1, Bryan A Ballif, Steven P Gygi
1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cell
|November 16, 2005
まとめ
この研究では,真核の初期因子3 (eIF3) 複合体が,細胞信号への反応としてタンパク質合成を制御するために,S6キナーゼ1 (S6K1) のダイナミックな活性化をオーケストラ化して,支架としてどのように作用するかを明らかにしました.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- リボソームタンパク質S6キナーゼ1 (S6K1) は,タンパク質合成に関与するトランスレーション,リン酸化標的の重要な調節体である.
- S6K1の活性化,基板相互作用,および翻訳開始におけるS6K1の役割を制御する正確な分子機構は,まだ完全に理解されていません.
研究 の 目的:
- 信号依存型トランスレーション初期におけるmTOR,S6K1,およびエウカリオット初期因子3 (eIF3) 複合体とのダイナミックな相互作用を解明する.
- 細胞刺激がeIF3複合体内のS6K1の結合と活性化をどのように調節するかを調査する.
主な方法:
- mTOR,ラプター,S6K1のeIF3複合体との関連と解離を追跡するために生化学的測定を用いた.
- 細胞刺激によるS6K1の酸化状態を,その水性モチーフで調査した.
- eIF4Bのような変換因子のeIF3複合体へのリン酸化依存的徴集を調査した.
主要な成果:
- 不活性なS6K1がeIF3複合体と結合し,そのアクティベーターであるmTOR/ラプターには結合しないことが示された.
- 細胞刺激により,mTOR/ラプターがeIF3に結合し,S6K1のリン酸化を促し,その後の解離と活性化を促すことが示された.
- 活性化されたS6K1は,eIF4Bなどの下流ターゲットを酸化し,翻訳開始複合体への採用を容易にすることを確認しました.
結論:
- eIF3複合体は,信号応答トランスレーション開始のための分子イベントのダイナミックな配列を調整する重要な支架として機能します.
- このメカニズムは,S6K1の活性化と基板のリン酸化を細胞のシグナルに反応して正確に調節することによって,効率的なタンパク質合成を保証します.
関連する概念動画
Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...

